Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger proteins (ZNFs) represent one of the largest and most diverse superfamilies of proteins in the human genome, characterized by small structural motifs stabilized by the coordination of one or more zinc ions [NIH, 2024]. These proteins primarily function as interaction modules that bind to DNA, RNA, or other proteins, making them central regulators of gene expression, chromatin remodeling, and DNA repair [Wikipedia, 2024]. In disease contexts, dysregulation of specific ZNFs like ZEB1 and SNAIL is a hallmark of the epithelial-mesenchymal transition (EMT) in cancer, while others are critical for viral replication, such as the HIV-1 nucleocapsid protein NCp7 [NIH, 2024; Wikipedia, 2024]. Historically considered "undruggable" due to their lack of traditional active sites, ZNFs are now targeted through innovative strategies including zinc-ejecting agents that disrupt the structural fold and thalidomide-based molecular glues that induce their proteasomal degradation [ScienceDaily, 2018; NIH, 2019]. Despite their therapeutic potential, the high abundance and structural similarity among ZNF family members present significant challenges for achieving the selectivity required to avoid systemic toxicity and off-target effects [NIH, 2019; ResearchGate, 2024].
Zinc ejection (displacement of Zn2+), targeted protein degradation (TPD) via E3 ligase recruitment, inhibition of DNA binding, and transcriptional modulation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and other zinc-structural proteins (ZNF).